What are the indications for ACE-Is and ARBs?
ACE-Is and ARBs are recommended for specific groups of CKD patients with increased urinary albumin excretion in which context use of these agents may be associated with and cardiovascular outcomes.97 In non-CKD patients, these drugs are indicated for the treatment of heart failure and for use soon after myocardial infarction, stroke, and in patients with high cardiovascular risk.98 100 The Oregon Health Resources Commission reported in 2005 on the use of ACE-Is in essential hypertension.